(BBIO) BridgeBio Pharma - Performance 70.8% in 12m
BBIO performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
20.75%
#17 in Peer-Group
Rel. Strength
90.15%
#757 in Stock-Universe
Total Return 12m
70.77%
#17 in Peer-Group
Total Return 5y
48.26%
#21 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 45.12 USD |
| 52 Week Low | 22.35 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 88.03 |
| Buy/Sell Signal +-5 | 1.86 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: BBIO (70.8%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: BBIO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BBIO
| Total Return (including Dividends) | BBIO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 15.70% | 3.36% | 5.25% |
| 3 Months | 40.23% | 15.73% | 24.13% |
| 12 Months | 70.77% | -7.02% | 14.15% |
| 5 Years | 48.26% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | BBIO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 88.3% | 4.4% | 81% |
| 3 Months | 70.9% | 78.8% | 96.9% |
| 12 Months | 82% | -85.8% | 44.9% |
| 5 Years | -25.3% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th82.50 | 11.95% | 9.93% |
| 3 Month | %th71.50 | 21.17% | 12.97% |
| 12 Month | %th91.50 | 83.67% | 49.60% |
| 5 Years | %th90.50 | 95.63% | -30.01% |
FAQs
Does BridgeBio Pharma (BBIO) outperform the market?
Yes,
over the last 12 months BBIO made 70.77%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months BBIO made 40.23%, while XBI made 15.73%.
Performance Comparison BBIO vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
BBIO vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3.6% | 10.5% | 50% | 57% |
| US NASDAQ 100 | QQQ | -3.4% | 10.4% | 49.3% | 58% |
| German DAX 40 | DAX | -1.5% | 17.1% | 37.8% | 42% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -3.5% | 12.5% | 46.6% | 51% |
| Hongkong Hang Seng | HSI | -3.3% | 9.6% | 30.5% | 32% |
| India NIFTY 50 | INDA | -1.8% | 12.2% | 49.7% | 72% |
| Brasil Bovespa | EWZ | -6.1% | 6.9% | 24.9% | 61% |
BBIO vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.3% | 9.8% | 45.9% | 46% |
| Consumer Discretionary | XLY | -3.1% | 12.5% | 57.6% | 53% |
| Consumer Staples | XLP | -4% | 15.1% | 48.3% | 62% |
| Energy | XLE | -4% | 8.6% | 54.1% | 71% |
| Financial | XLF | -4.4% | 10.6% | 45.1% | 41% |
| Health Care | XLV | -3.1% | 13.6% | 57.4% | 75% |
| Industrial | XLI | -3.7% | 11.5% | 42.1% | 46% |
| Materials | XLB | -5.9% | 11.4% | 45.5% | 65% |
| Real Estate | XLRE | -3.6% | 14.7% | 50.3% | 58% |
| Technology | XLK | -4.4% | 7% | 47.7% | 60% |
| Utilities | XLU | -2.6% | 13.9% | 46.8% | 48% |
| Aerospace & Defense | XAR | -1.5% | 8.6% | 31.4% | 21% |
| Biotech | XBI | -4.6% | 12.3% | 63.2% | 78% |
| Homebuilder | XHB | -6.1% | 8.7% | 57.2% | 65% |
| Retail | XRT | -6.2% | 10.7% | 54.3% | 59% |
BBIO vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -4.6% | 7.26% | 58.4% | 78% |
| Natural Gas | UNG | 5.9% | 25.5% | 66.8% | 73% |
| Gold | GLD | -3.9% | 16.9% | 29.4% | 32% |
| Silver | SLV | -4.7% | 8.8% | 32.6% | 53% |
| Copper | CPER | -2.7% | 11.1% | 32.9% | 60% |
BBIO vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -1.8% | 14.7% | 53.4% | 73% |
| iShares High Yield Corp. Bond | HYG | -2.5% | 14.1% | 51.1% | 61% |